I'm giving the variant update at the SAVE meeting on Monday so I thought I'd put out a preview for comment.
We are now at our 4th 'high water' mark since the Omicron wave based on wastewater surveillance.
1/
I thought I would give an abbreviated summary of the last year in variants.
A little over a year ago BA.2.86 started circulating, a lineage that was almost certainly derived from a persistent infection. 2/
BA.2.86 was pretty fit, but it was still sensitive to a lot of Class 1 antibodies.
However, it quickly picked up S:L455S (making it JN.1), which evaded these antibodies, and it was off to the races. 3/
JN.1 played around with a lot of mutations, but its favorite was F456L, a change that it independently picked up at least 20 times. 4/
We then started seeing lineages that combined 456L with the old favorite R346T, which was the same change that BA.4/5 picked up during the summer 2 years ago.
This happened lots of times, but the best know was probably KP.2. 5/
But those lineages got some competition when another 456L lineage picked up R493E (KP.3).
For whatever reason this really only happened once. I'm not sure why. It was a C->G mutation, which is rare.
KP.3 seemed to be fitter than the 456L/346T gang. 6/
I always expected KP.3 to pick up R346T, but there hasn't appeared to be much selective pressure for that to happen. There's probably some redundancy in 346T/493E advantages.
7/
Then the 346T/456L group found a neat trick. They deleted position S31, which gave them the leg up again.
8/
But of course, KP.3 figured out that it could do that too.
The S31 deletion has occurred lots of times now, but the fittest among them seems to be KP.3.1.1. 9/
So what does the S31 deletion do. It's been reported to both increase fitness (higher infectivity in pseudotype assays), and antibody evasion.
The deletion introduces a glycosylation site, but it also restores the insertions/deletion balance in that part of Spike. 10/
RaTG-13 had a glycosylation site at this position too, and I've seen it introduced in lots of cryptic lineages.
However, I never saw the 31 deletion until the JN.1 insertion occurred. Probably because of the insertion/deletion balance thing.
11/
If I were smart I would put a 3D structure here showing why they insertion/deletion balance is important, but I'm not that smart (and it's just a theory).
12/
So what are we watching now?
There is a chimera-of-chimeras in China called XDV.1 that is doing pretty well there, but not really anywhere else.
Its spike is derived from JN.1, but it doesn't have any of the 'advanced' changes.
It does have the XBB Orf9b:I5T though.
13/
Finally there is the new chimera that just got designated, XEC. This one just appeared in June and has fared pretty well. I don't think it could keep up with KP.3.1.1 currently, but if it picks up a few more changes it might.
14/
Overall it's an odd time. It's pretty clear that KP.3.1.1 (and equivalent) is going to have a sweep the world the way that JN.1 did, but I'm not sure what happens after that.
We'll be watching.
15/15
• • •
Missing some Tweet in this thread? You can try to
force a refresh
I obviously knew there was some manipulation of post metrics on social media, but I really didn’t realize just how hard this platform slams the breaks on posts it doesn’t like.
Here’s my experiment.
1/
This weekend I posted 3 threads.
1. on a cryptic lineage 2. on H5N1 3. on seasonal respiratory viruses
Each time I posted the threads on X and bsky at the same time.
2/
The three threads each got roughly the same attention on bsky.
However, on X the first 2 each had hundreds of RTs and over 1k likes.
The 3rd was practically invisible. It had only 5 RTs and 28 likes after 2 days. Over 40-times fewer views.
3/
I’ve found cryptic lineages from sequencing wastewater.
I’ve found cryptic lineages from screening databases.
This is the first time I’ve found a cryptic lineage from social media.
This was an interesting story.
1/
Earlier this summer someone poked me to ask what the deal was with Coeur d’Alene, ID whose COVID numbers were consistently the highest in the country (by far).
I couldn’t find the post, so if this was you, please take credit. 2/
It did look suspicious, extremely high and sustained COVID levels, but my sources said they didn’t have any out of the ordinary case levels.
It’s been 2 days, 143 comments, and I’ve been called lots of bad names.
Here’s what I learned about protein based Novavax (NV) vs mRNA COVID vaccines. 1/
The pretty universally agreed on difference is that Novavax has fewer side effects.
If you have bad vaccine reactions, it is probably the better choice.
2/
There are other differences too. NV is protein based, so the immune response is antibody focused, while the mRNA is response is broader and produces both antibodies and CTLs.
3/
It’s been 2 years since BA.2.86 first appeared (and I’m give the variant update to SAVE on Monday), so I thought I would do a little summary about this era of SARS-CoV-2 evolution. 1/
SARS-CoV-2 lineages come up with new constellations of mutations in 3 main ways. 1. Sequential acquisition of mutations during normal circulation. 2. Recombination. 3. Sweeping new lineages (almost certainly from persistent infections).
2/
BA.2.86 was one of the sweeping changes. When it first appeared in Israel I thought it was a persistent infection, most of which never spread. Then it appeared in Denmark too. 3/